WeVote
Log In

Bill

Bill

H 4043

An Act relative to copay assistance for medications

194th Legislature (2025-2026) Introduced by Manny Cruz

Massachusetts bill regulates copay assistance programs to balance patient medication affordability with insurance market transparency and equitable access considerations.

Accompanied a study order, see H4789
0
WeVote Research Nonpartisan
Bill Summary · H 4043

Legislative bill overview

H 4043 aims to regulate copay assistance programs that help patients afford high-cost medications by covering or reducing their out-of-pocket expenses. The bill addresses how these programs interact with insurance coverage and patient access to necessary drugs.

Why is this important

Copay assistance programs can determine whether patients can actually afford prescribed medications, particularly for chronic or expensive conditions. However, these programs can also affect insurance market dynamics, drug pricing transparency, and which patients receive help, making the policy balance significant.

Potential points of contention

  • Insurance market impacts: Copay assistance may artificially inflate demand for higher-cost drugs or obscure true medication costs, potentially affecting insurance premiums for other patients
  • Equity concerns: Questions about whether assistance programs create a two-tiered system where some patients get help while others pay full costs, and whether programs benefit wealthy patients more than those in need
  • Regulatory scope: Debate over whether Massachusetts should regulate these programs independently or if federal oversight is more appropriate, given the complexity of drug pricing and insurance across state lines

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.